Improved DL-PDT Effectiveness: CAL pre-treatment boosted the therapeutic impact of daylight photodynamic therapy (DL-PDT) for ...

Biofrontera Inc. has completed enrollment for its Phase 3 clinical trial of Ameluz® photodynamic therapy (PDT), aiming to treat mild to moderate actinic keratoses (AKs) on the neck, trunk ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 24, 2025 /EINPresswire / -- The market size for actinic keratosis ... expanding application of photodynamic therapy, increased awareness of cosmetic ...

Immune checkpoint inhibitor therapy for any cancer was associated with a significant reduction of actinic keratoses, ...

FutureWise Research, a leading provider of market intelligence and strategic insights, has published a comprehensive report on the Actinic Keratosis Treatment market. The report provides an in-depth ...

Cutaneous squamous cell carcinoma (SCC) and inflammation of actinic keratosis (AK ... Ten of these 14 patients discontinued therapy with sorafenib: 7 patients as a result of disease progression ...

The randomised, double-blind trial is comparing Ameluz with a vehicle gel in treating AK on the extremities, neck and trunk, using the RhodoLED lamp photodynamic therapy (PDT). It has been ...